Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase

Nature Communications

Volumn 6, Issue , 2015, Pages

  Glukhova, Alisa ^a   Hinkovska Galcheva, Vania ^b   Kelly, Robert ^b   Abe, Akira ^b,c   Shayman, James A ^b   Tesmer, John J G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE A2; CHOLESTEROL; LUNG SURFACTANT;

BIOCHEMISTRY; CRYSTAL STRUCTURE; DISEASE TREATMENT; DRUG; ENZYME ACTIVITY; MOLECULAR ANALYSIS; MUTATION; PHOSPHOLIPID;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EMBRYO; ENZYME STRUCTURE; HUMAN; HUMAN CELL; LYSOSOME; MEMBRANE BINDING; MISSENSE MUTATION; PROTEIN INTERACTION; AMINO ACID SEQUENCE; CHEMISTRY; ENZYMOLOGY; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; PROTEIN CONFORMATION; SEQUENCE ALIGNMENT; SIZE EXCLUSION CHROMATOGRAPHY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; CHOLESTEROL; CHROMATOGRAPHY, GEL; CRYSTALLOGRAPHY, X-RAY; HUMANS; LYSOSOMES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPASES A2; PROTEIN CONFORMATION; PULMONARY SURFACTANTS; SEQUENCE ALIGNMENT;

EID: 84923873052     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7250     Document Type: Article

References (55)

1. 2. Prog. Lipid Res. 50, 1-13 (2011).
2. Kunnen, S. & Van Eck, M. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? J. Lipid Res. 53, 1783-1799 (2012).
3. Abe, A. et al. Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J. Biol. Chem. 279, 42605-42611 (2004).
4. Hiraoka, M. et al. Lysosomal phospholipase A2 and phospholipidosis. Mol. Cell. Biol. 26, 6139-6148 (2006).
5. Paduraru, C. et al. Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition. Proc. Natl Acad. Sci. USA 110, 5097-5102 (2013).
6. Shayman, J. A. & Abe, A. Drug induced phospholipidosis: an acquired lysosomal storage disorder. Biochim. Biophys. Acta 1831, 602-611 (2013).
7. Schneider, B. E. et al. Lysosomal phospholipase A2: A novel player in host immunity to Mycobacterium tuberculosis. Eur. J. Immunol. 00, 1-11 (2014).
8. Fielding, C. J. & Fielding, P. E. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36, 211-228 (1995).
9. Calabresi, L., Simonelli, S., Gomaraschi, M. & Franceschini, G. Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease. Atherosclerosis 222, 299-306 (2012).
10. Kuivenhoven, J. A. et al. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38, 191-205 (1997).
11. Rousset, X. et al. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice. J. Pharmacol. Exp. Ther. 335, 140-148 (2010).
12. Kingwell, B. A., Chapman, M. J., Kontush, A. & Miller, N. E. HDL-targeted therapies: progress, failures and future. Nat. Rev. Drug Discov. 13, 445-464 (2014).
13. Peelman, F. et al. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling. Protein Sci. 7, 587-599 (1998).
14. Hiraoka, M., Abe, A. & Shayman, J. A. Structure and function of lysosomal phospholipase A2: identification of the catalytic triad and the role of cysteine residues. J. Lipid Res. 46, 2441-2447 (2005).
15. Arpigny, J. L. & Jaeger, K. E. Bacterial lipolytic enzymes: classification and properties. Biochem. J. 343, 177-183 (1999).
16. Ollis, D. L., Cheah, E., Cygler, M. & Dijkstra, B. The α/β hydrolase fold. Protein Eng. 5, 197-211 (1992).
17. Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V. & Kokotos, G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 111, 6130-6185 (2011).
18. Nardini, M. & Dijkstra, B. W. α/β hydrolase fold enzymes: the family keeps growing. Curr. Opin. Struct. Biol. 9, 732-737 (1999).
19. Schrag, J. D. et al. The open conformation of a Pseudomonas lipase. Structure 5, 187-202 (1997).
20. Stewart, D. E., Sarkar, A. & Wampler, J. E. Occurrence and role of cis peptide bonds in protein structures. J. Mol. Biol. 214, 253-260 (1990).
21. Dundas, J. et al. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res. 34, W116-W118 (2006).
22. van Tilbeurgh, H. et al. Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography. Nature 362, 814-820 (1993).
23. Abe, A., Kelly, R. & Shayman, J. A. The measurement of lysosomal phospholipase A2 activity in plasma. J. Lipid Res. 51, 2464-2470 (2010).
24. Boone, T., Meininger, D. P., Schwarz, M. & Shan, B. Modified lecithin-cholesterol acyltransferase enzymes. US Patent 008168416B2Amgen Inc (2012).
25. Francone, O. L. & Fielding, C. J. Effects of site-directed mutagenesis at residues cysteine-31 and cysteine-184 on lecithin-cholesterol acyltransferase activity. Proc. Natl Acad. Sci. USA 88, 1716-1720 (1991).
26. Jauhiainen, M., Stevenson, K. J. & Dolphin, P. J. Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site. J. Biol. Chem. 263, 6525-6533 (1988).
27. Verger, R. 'Interfacial activation'of lipases: facts and artifacts. Trends Biotechnol. 15, 32-38 (1997).
28. Vickaryous, N. K. et al. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward α- and β-substrate lipoproteins. Biochim. Biophys. Acta 1646, 164-172 (2003).
29. Abe, A., Hiraoka, M. & Shayman, J. A. Positional specificity of lysosomal phospholipase A2. J. Lipid Res. 47, 2268-2279 (2006).
30. Abe, A. & Shayman, J. A. The role of negatively charged lipids in lysosomal phospholipase A2 function. J. Lipid Res. 50, 2027-2035 (2009).
31. Pownall, H. J., Pao, Q. & Massey, J. B. Acyl chain and headgroup specificity of human plasma lecithin:cholesterol acyltransferase. Separation of matrix and molecular specificities. J. Biol. Chem. 260, 2146-2152 (1985).
32. Abe, A., Hiraoka, M. & Shayman, J. A. The acylation of lipophilic alcohols by lysosomal phospholipase A2. J. Lipid Res. 48, 2255-2263 (2007).
33. Kitabatake, K., Piran, U., Kamio, Y., Doi, Y. & Nishida, T. Purification of human plasma lecithin:cholesterol acyltransferase and its specificity towards the acyl acceptor. Biochim. Biophys. Acta 573, 145-154 (1979).
34. Adimoolam, S., Jin, L., Grabbe, E., Shieh, J. J. & Jonas, A. Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K). J. Biol. Chem. 273, 32561-32567 (1998).
35. Peelman, F. et al. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity. J. Lipid Res. 40, 59-69 (1999).
36. Qu, S. J., Fan, H. Z., Blanco-Vaca, F. & Pownall, H. J. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase. J. Lipid Res. 36, 967-974 (1995).
37. Calabresi, L. et al. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120, 628-635 (2009).
38. Miettinen, H. E. et al. Molecular genetic study of finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230Arg mutation (LCATFin) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 18, 591-598 (1998).
39. Gotoda, T. et al. Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet 338, 778-781 (1991).
40. Murray, K. R. et al. Probing the 121-136 domain of lecithin:cholesterol acyltransferase using antibodies. Arch. Biochem. Biophys. 385, 267-275 (2001).
41. Vanloo, B. et al. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease. J. Lipid Res. 41, 752-761 (2000).
42. Kabsch, W. XDS. Acta Crystallogr. Sect. D 66, 125-132 (2010).
43. Winn et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. Sect. D 67, 235-242 (2011).
44. Schneider, T. R. & Sheldrick, G. M. Substructure solution with SHELXD. Acta Crystallogr. Sect. D 58, 1772-1779 (2002).
45. Adams, P. D. et al. Phenix: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D 66, 213-221 (2010).
46. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
47. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658-674 (2007).
48. Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. Sect. D 67, 355-367 (2011).
49. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D 66, 486-501 (2010).
50. Pettersen, E. F. et al. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
51. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D 66, 12-21 (2010).
52. Abe, A., Shayman, J. A. & Radin, N. S. A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides. J. Biol. Chem. 271, 14383-14389 (1996).
53. Dolinsky, T. J., Nielsen, J. E., McCammon, J. A. & Baker, N. A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665-W667 (2004).
54. Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl Acad. Sci. USA 98, 10037-10041 (2001).
55. Schindler, P. A., Settineri, C. A., Collet, X., Fielding, C. J. & Burlingame, A. L. Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion. Protein Sci. 4, 791-803 (1995).